搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Synechococcus sp. 30S ribosomal protein S19 (rpsS) CSB-YP646454SAAY
CSB-EP646454SAAY
CSB-BP646454SAAY
CSB-MP646454SAAY
CSB-EP646454SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L18 (rplR) CSB-YP646455SAAY
CSB-EP646455SAAY
CSB-BP646455SAAY
CSB-MP646455SAAY
CSB-EP646455SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Transcriptional repressor NrdR (nrdR) CSB-YP646456SAAY
CSB-EP646456SAAY
CSB-BP646456SAAY
CSB-MP646456SAAY
CSB-EP646456SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Protein grpE (grpE) CSB-YP646457SAAY
CSB-EP646457SAAY
CSB-BP646457SAAY
CSB-MP646457SAAY
CSB-EP646457SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP646458SAAY
CSB-EP646458SAAY
CSB-BP646458SAAY
CSB-MP646458SAAY
CSB-EP646458SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP646459SAAY
CSB-EP646459SAAY
CSB-BP646459SAAY
CSB-MP646459SAAY
CSB-EP646459SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase subunit I (ndhI) CSB-YP646460SAAY
CSB-EP646460SAAY
CSB-BP646460SAAY
CSB-MP646460SAAY
CSB-EP646460SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable 2-phosphosulfolactate phosphatase (comB) CSB-YP646461SAAY
CSB-EP646461SAAY
CSB-BP646461SAAY
CSB-MP646461SAAY
CSB-EP646461SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Urease accessory protein UreG (ureG) CSB-YP646462SAAY
CSB-EP646462SAAY
CSB-BP646462SAAY
CSB-MP646462SAAY
CSB-EP646462SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase chain 4 1 (ndhD1), partial CSB-YP646463SAAY
CSB-EP646463SAAY
CSB-BP646463SAAY
CSB-MP646463SAAY
CSB-EP646463SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Bifunctional protein pyrR (pyrR) CSB-YP646464SAAY
CSB-EP646464SAAY
CSB-BP646464SAAY
CSB-MP646464SAAY
CSB-EP646464SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable 30S ribosomal protein PSRP-3 (CYA_0331) CSB-YP646465SAAY
CSB-EP646465SAAY
CSB-BP646465SAAY
CSB-MP646465SAAY
CSB-EP646465SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP646466SAAY
CSB-EP646466SAAY
CSB-BP646466SAAY
CSB-MP646466SAAY
CSB-EP646466SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP646467SAAY
CSB-EP646467SAAY
CSB-BP646467SAAY
CSB-MP646467SAAY
CSB-EP646467SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP646468SAAY
CSB-EP646468SAAY
CSB-BP646468SAAY
CSB-MP646468SAAY
CSB-EP646468SAAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium etli Triosephosphate isomerase 2 (tpiA2) CSB-YP646469RKK
CSB-EP646469RKK
CSB-BP646469RKK
CSB-MP646469RKK
CSB-EP646469RKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium etli Hydroxyethylthiazole kinase (thiM) CSB-YP646470RKK
CSB-EP646470RKK
CSB-BP646470RKK
CSB-MP646470RKK
CSB-EP646470RKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium etli tRNA modification GTPase MnmE (mnmE) CSB-YP646471RKK
CSB-EP646471RKK
CSB-BP646471RKK
CSB-MP646471RKK
CSB-EP646471RKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium etli 3-isopropylmalate dehydrogenase (leuB) CSB-YP646472RKK
CSB-EP646472RKK
CSB-BP646472RKK
CSB-MP646472RKK
CSB-EP646472RKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium etli 50S ribosomal protein L27 (rpmA) CSB-YP646473RKK
CSB-EP646473RKK
CSB-BP646473RKK
CSB-MP646473RKK
CSB-EP646473RKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>